Global Intracranial Therapeutic Market Research Report 2023

Publisher Name :
Date: 20-Jan-2023
No. of pages: 92
Inquire Before Buying

Highlights

The global Intracranial Therapeutic market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Intracranial Therapeutic is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Intracranial Therapeutic is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Intracranial Therapeutic in Spinal Muscular Atrophy (SMA) is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Intracranial Therapeutic include Novartis AG, BioMarin, CORESTEM Inc., Alaunos Therapeutics, Inc., Apic Bio, Stemedica Cell Technologies, Inc., Voyager Therapeutics, Bayer AG and Abeona Therapeutics, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Intracranial Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intracranial Therapeutic.

The Intracranial Therapeutic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Intracranial Therapeutic market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Intracranial Therapeutic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

By Company

- Novartis AG

- BioMarin

- CORESTEM Inc.

- Alaunos Therapeutics, Inc.

- Apic Bio

- Stemedica Cell Technologies, Inc.

- Voyager Therapeutics

- Bayer AG

- Abeona Therapeutics

- Spark Therapeutics

Segment by Type

- Cell-based Therapy

- Gene Therapy

- Enzyme Replacement Therapy

Segment by Application

- Spinal Muscular Atrophy (SMA)

- Multiple Sclerosis

- Batten Disease

- Amyotrophic Lateral Sclerosis

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Intracranial Therapeutic companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Global Intracranial Therapeutic Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intracranial Therapeutic Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Cell-based Therapy
1.2.3 Gene Therapy
1.2.4 Enzyme Replacement Therapy
1.3 Market by Application
1.3.1 Global Intracranial Therapeutic Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Spinal Muscular Atrophy (SMA)
1.3.3 Multiple Sclerosis
1.3.4 Batten Disease
1.3.5 Amyotrophic Lateral Sclerosis
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Intracranial Therapeutic Market Perspective (2018-2029)
2.2 Intracranial Therapeutic Growth Trends by Region
2.2.1 Global Intracranial Therapeutic Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Intracranial Therapeutic Historic Market Size by Region (2018-2023)
2.2.3 Intracranial Therapeutic Forecasted Market Size by Region (2024-2029)
2.3 Intracranial Therapeutic Market Dynamics
2.3.1 Intracranial Therapeutic Industry Trends
2.3.2 Intracranial Therapeutic Market Drivers
2.3.3 Intracranial Therapeutic Market Challenges
2.3.4 Intracranial Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Intracranial Therapeutic Players by Revenue
3.1.1 Global Top Intracranial Therapeutic Players by Revenue (2018-2023)
3.1.2 Global Intracranial Therapeutic Revenue Market Share by Players (2018-2023)
3.2 Global Intracranial Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Intracranial Therapeutic Revenue
3.4 Global Intracranial Therapeutic Market Concentration Ratio
3.4.1 Global Intracranial Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intracranial Therapeutic Revenue in 2022
3.5 Intracranial Therapeutic Key Players Head office and Area Served
3.6 Key Players Intracranial Therapeutic Product Solution and Service
3.7 Date of Enter into Intracranial Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Intracranial Therapeutic Breakdown Data by Type
4.1 Global Intracranial Therapeutic Historic Market Size by Type (2018-2023)
4.2 Global Intracranial Therapeutic Forecasted Market Size by Type (2024-2029)
5 Intracranial Therapeutic Breakdown Data by Application
5.1 Global Intracranial Therapeutic Historic Market Size by Application (2018-2023)
5.2 Global Intracranial Therapeutic Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Intracranial Therapeutic Market Size (2018-2029)
6.2 North America Intracranial Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Intracranial Therapeutic Market Size by Country (2018-2023)
6.4 North America Intracranial Therapeutic Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Intracranial Therapeutic Market Size (2018-2029)
7.2 Europe Intracranial Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Intracranial Therapeutic Market Size by Country (2018-2023)
7.4 Europe Intracranial Therapeutic Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Intracranial Therapeutic Market Size (2018-2029)
8.2 Asia-Pacific Intracranial Therapeutic Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Intracranial Therapeutic Market Size by Region (2018-2023)
8.4 Asia-Pacific Intracranial Therapeutic Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Intracranial Therapeutic Market Size (2018-2029)
9.2 Latin America Intracranial Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Intracranial Therapeutic Market Size by Country (2018-2023)
9.4 Latin America Intracranial Therapeutic Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Intracranial Therapeutic Market Size (2018-2029)
10.2 Middle East & Africa Intracranial Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Intracranial Therapeutic Market Size by Country (2018-2023)
10.4 Middle East & Africa Intracranial Therapeutic Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Detail
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Intracranial Therapeutic Introduction
11.1.4 Novartis AG Revenue in Intracranial Therapeutic Business (2018-2023)
11.1.5 Novartis AG Recent Development
11.2 BioMarin
11.2.1 BioMarin Company Detail
11.2.2 BioMarin Business Overview
11.2.3 BioMarin Intracranial Therapeutic Introduction
11.2.4 BioMarin Revenue in Intracranial Therapeutic Business (2018-2023)
11.2.5 BioMarin Recent Development
11.3 CORESTEM Inc.
11.3.1 CORESTEM Inc. Company Detail
11.3.2 CORESTEM Inc. Business Overview
11.3.3 CORESTEM Inc. Intracranial Therapeutic Introduction
11.3.4 CORESTEM Inc. Revenue in Intracranial Therapeutic Business (2018-2023)
11.3.5 CORESTEM Inc. Recent Development
11.4 Alaunos Therapeutics, Inc.
11.4.1 Alaunos Therapeutics, Inc. Company Detail
11.4.2 Alaunos Therapeutics, Inc. Business Overview
11.4.3 Alaunos Therapeutics, Inc. Intracranial Therapeutic Introduction
11.4.4 Alaunos Therapeutics, Inc. Revenue in Intracranial Therapeutic Business (2018-2023)
11.4.5 Alaunos Therapeutics, Inc. Recent Development
11.5 Apic Bio
11.5.1 Apic Bio Company Detail
11.5.2 Apic Bio Business Overview
11.5.3 Apic Bio Intracranial Therapeutic Introduction
11.5.4 Apic Bio Revenue in Intracranial Therapeutic Business (2018-2023)
11.5.5 Apic Bio Recent Development
11.6 Stemedica Cell Technologies, Inc.
11.6.1 Stemedica Cell Technologies, Inc. Company Detail
11.6.2 Stemedica Cell Technologies, Inc. Business Overview
11.6.3 Stemedica Cell Technologies, Inc. Intracranial Therapeutic Introduction
11.6.4 Stemedica Cell Technologies, Inc. Revenue in Intracranial Therapeutic Business (2018-2023)
11.6.5 Stemedica Cell Technologies, Inc. Recent Development
11.7 Voyager Therapeutics
11.7.1 Voyager Therapeutics Company Detail
11.7.2 Voyager Therapeutics Business Overview
11.7.3 Voyager Therapeutics Intracranial Therapeutic Introduction
11.7.4 Voyager Therapeutics Revenue in Intracranial Therapeutic Business (2018-2023)
11.7.5 Voyager Therapeutics Recent Development
11.8 Bayer AG
11.8.1 Bayer AG Company Detail
11.8.2 Bayer AG Business Overview
11.8.3 Bayer AG Intracranial Therapeutic Introduction
11.8.4 Bayer AG Revenue in Intracranial Therapeutic Business (2018-2023)
11.8.5 Bayer AG Recent Development
11.9 Abeona Therapeutics
11.9.1 Abeona Therapeutics Company Detail
11.9.2 Abeona Therapeutics Business Overview
11.9.3 Abeona Therapeutics Intracranial Therapeutic Introduction
11.9.4 Abeona Therapeutics Revenue in Intracranial Therapeutic Business (2018-2023)
11.9.5 Abeona Therapeutics Recent Development
11.10 Spark Therapeutics
11.10.1 Spark Therapeutics Company Detail
11.10.2 Spark Therapeutics Business Overview
11.10.3 Spark Therapeutics Intracranial Therapeutic Introduction
11.10.4 Spark Therapeutics Revenue in Intracranial Therapeutic Business (2018-2023)
11.10.5 Spark Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Intracranial Therapeutic Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Cell-based Therapy
Table 3. Key Players of Gene Therapy
Table 4. Key Players of Enzyme Replacement Therapy
Table 5. Global Intracranial Therapeutic Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Intracranial Therapeutic Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Intracranial Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Intracranial Therapeutic Market Share by Region (2018-2023)
Table 9. Global Intracranial Therapeutic Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Intracranial Therapeutic Market Share by Region (2024-2029)
Table 11. Intracranial Therapeutic Market Trends
Table 12. Intracranial Therapeutic Market Drivers
Table 13. Intracranial Therapeutic Market Challenges
Table 14. Intracranial Therapeutic Market Restraints
Table 15. Global Intracranial Therapeutic Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Intracranial Therapeutic Market Share by Players (2018-2023)
Table 17. Global Top Intracranial Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intracranial Therapeutic as of 2022)
Table 18. Ranking of Global Top Intracranial Therapeutic Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Intracranial Therapeutic Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Intracranial Therapeutic Product Solution and Service
Table 22. Date of Enter into Intracranial Therapeutic Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Intracranial Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Intracranial Therapeutic Revenue Market Share by Type (2018-2023)
Table 26. Global Intracranial Therapeutic Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Intracranial Therapeutic Revenue Market Share by Type (2024-2029)
Table 28. Global Intracranial Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Intracranial Therapeutic Revenue Market Share by Application (2018-2023)
Table 30. Global Intracranial Therapeutic Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Intracranial Therapeutic Revenue Market Share by Application (2024-2029)
Table 32. North America Intracranial Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Intracranial Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Intracranial Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Intracranial Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Intracranial Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Intracranial Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Intracranial Therapeutic Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Intracranial Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Intracranial Therapeutic Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Intracranial Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Intracranial Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Intracranial Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Intracranial Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Intracranial Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Intracranial Therapeutic Market Size by Country (2024-2029) & (US$ Million)
Table 47. Novartis AG Company Detail
Table 48. Novartis AG Business Overview
Table 49. Novartis AG Intracranial Therapeutic Product
Table 50. Novartis AG Revenue in Intracranial Therapeutic Business (2018-2023) & (US$ Million)
Table 51. Novartis AG Recent Development
Table 52. BioMarin Company Detail
Table 53. BioMarin Business Overview
Table 54. BioMarin Intracranial Therapeutic Product
Table 55. BioMarin Revenue in Intracranial Therapeutic Business (2018-2023) & (US$ Million)
Table 56. BioMarin Recent Development
Table 57. CORESTEM Inc. Company Detail
Table 58. CORESTEM Inc. Business Overview
Table 59. CORESTEM Inc. Intracranial Therapeutic Product
Table 60. CORESTEM Inc. Revenue in Intracranial Therapeutic Business (2018-2023) & (US$ Million)
Table 61. CORESTEM Inc. Recent Development
Table 62. Alaunos Therapeutics, Inc. Company Detail
Table 63. Alaunos Therapeutics, Inc. Business Overview
Table 64. Alaunos Therapeutics, Inc. Intracranial Therapeutic Product
Table 65. Alaunos Therapeutics, Inc. Revenue in Intracranial Therapeutic Business (2018-2023) & (US$ Million)
Table 66. Alaunos Therapeutics, Inc. Recent Development
Table 67. Apic Bio Company Detail
Table 68. Apic Bio Business Overview
Table 69. Apic Bio Intracranial Therapeutic Product
Table 70. Apic Bio Revenue in Intracranial Therapeutic Business (2018-2023) & (US$ Million)
Table 71. Apic Bio Recent Development
Table 72. Stemedica Cell Technologies, Inc. Company Detail
Table 73. Stemedica Cell Technologies, Inc. Business Overview
Table 74. Stemedica Cell Technologies, Inc. Intracranial Therapeutic Product
Table 75. Stemedica Cell Technologies, Inc. Revenue in Intracranial Therapeutic Business (2018-2023) & (US$ Million)
Table 76. Stemedica Cell Technologies, Inc. Recent Development
Table 77. Voyager Therapeutics Company Detail
Table 78. Voyager Therapeutics Business Overview
Table 79. Voyager Therapeutics Intracranial Therapeutic Product
Table 80. Voyager Therapeutics Revenue in Intracranial Therapeutic Business (2018-2023) & (US$ Million)
Table 81. Voyager Therapeutics Recent Development
Table 82. Bayer AG Company Detail
Table 83. Bayer AG Business Overview
Table 84. Bayer AG Intracranial Therapeutic Product
Table 85. Bayer AG Revenue in Intracranial Therapeutic Business (2018-2023) & (US$ Million)
Table 86. Bayer AG Recent Development
Table 87. Abeona Therapeutics Company Detail
Table 88. Abeona Therapeutics Business Overview
Table 89. Abeona Therapeutics Intracranial Therapeutic Product
Table 90. Abeona Therapeutics Revenue in Intracranial Therapeutic Business (2018-2023) & (US$ Million)
Table 91. Abeona Therapeutics Recent Development
Table 92. Spark Therapeutics Company Detail
Table 93. Spark Therapeutics Business Overview
Table 94. Spark Therapeutics Intracranial Therapeutic Product
Table 95. Spark Therapeutics Revenue in Intracranial Therapeutic Business (2018-2023) & (US$ Million)
Table 96. Spark Therapeutics Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Intracranial Therapeutic Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Intracranial Therapeutic Market Share by Type: 2022 VS 2029
Figure 3. Cell-based Therapy Features
Figure 4. Gene Therapy Features
Figure 5. Enzyme Replacement Therapy Features
Figure 6. Global Intracranial Therapeutic Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Intracranial Therapeutic Market Share by Application: 2022 VS 2029
Figure 8. Spinal Muscular Atrophy (SMA) Case Studies
Figure 9. Multiple Sclerosis Case Studies
Figure 10. Batten Disease Case Studies
Figure 11. Amyotrophic Lateral Sclerosis Case Studies
Figure 12. Intracranial Therapeutic Report Years Considered
Figure 13. Global Intracranial Therapeutic Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Intracranial Therapeutic Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Intracranial Therapeutic Market Share by Region: 2022 VS 2029
Figure 16. Global Intracranial Therapeutic Market Share by Players in 2022
Figure 17. Global Top Intracranial Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intracranial Therapeutic as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Intracranial Therapeutic Revenue in 2022
Figure 19. North America Intracranial Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Intracranial Therapeutic Market Share by Country (2018-2029)
Figure 21. United States Intracranial Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Intracranial Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Intracranial Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Intracranial Therapeutic Market Share by Country (2018-2029)
Figure 25. Germany Intracranial Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Intracranial Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Intracranial Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Intracranial Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Intracranial Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Intracranial Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Intracranial Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Intracranial Therapeutic Market Share by Region (2018-2029)
Figure 33. China Intracranial Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Intracranial Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Intracranial Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Intracranial Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Intracranial Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Intracranial Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Intracranial Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Intracranial Therapeutic Market Share by Country (2018-2029)
Figure 41. Mexico Intracranial Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Intracranial Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Intracranial Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Intracranial Therapeutic Market Share by Country (2018-2029)
Figure 45. Turkey Intracranial Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Intracranial Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Novartis AG Revenue Growth Rate in Intracranial Therapeutic Business (2018-2023)
Figure 48. BioMarin Revenue Growth Rate in Intracranial Therapeutic Business (2018-2023)
Figure 49. CORESTEM Inc. Revenue Growth Rate in Intracranial Therapeutic Business (2018-2023)
Figure 50. Alaunos Therapeutics, Inc. Revenue Growth Rate in Intracranial Therapeutic Business (2018-2023)
Figure 51. Apic Bio Revenue Growth Rate in Intracranial Therapeutic Business (2018-2023)
Figure 52. Stemedica Cell Technologies, Inc. Revenue Growth Rate in Intracranial Therapeutic Business (2018-2023)
Figure 53. Voyager Therapeutics Revenue Growth Rate in Intracranial Therapeutic Business (2018-2023)
Figure 54. Bayer AG Revenue Growth Rate in Intracranial Therapeutic Business (2018-2023)
Figure 55. Abeona Therapeutics Revenue Growth Rate in Intracranial Therapeutic Business (2018-2023)
Figure 56. Spark Therapeutics Revenue Growth Rate in Intracranial Therapeutic Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs